|
| Status |
Public on May 01, 2010 |
| Title |
GSK-3 inhibitor effect on MLL leukemia cells - 3 |
| Sample type |
RNA |
| |
|
| Source name |
Human Leukemia cell line RS4.11
|
| Organism |
Homo sapiens |
| Characteristics |
treatment protocol: GSK-3 inhibitor (SB216763) treated for 20 hours
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Trizol
|
| Label |
Biotin
|
| Label protocol |
GeneChip® WT Terminal Labeling Kit(Affymetrix)
|
| |
|
| Hybridization protocol |
GeneChip® Hybridization, Wash and Stain Kit
|
| Scan protocol |
GeneChip® Scanner 3000 7G
|
| Description |
Study the effect of GSK-3 inhibition on MLL leukemia cells
|
| Data processing |
Expression Console (Affymetrix)
affymetrix-algorithm-name = rma-gene-default.
|
| |
|
| Submission date |
Jan 04, 2010 |
| Last update date |
Apr 21, 2010 |
| Contact name |
Michael L Cleary |
| E-mail(s) |
[email protected]
|
| Phone |
(650) 723-5471
|
| Fax |
(650) 498-6222
|
| URL |
http:// http://med.stanford.edu/profiles/pathology/researcher/Michael_Cleary/ At Stanford
|
| Organization name |
Stanford University
|
| Department |
Pathology
|
| Street address |
Room L232, Stanford Medical Center
|
| City |
Stanford |
| State/province |
CA |
| ZIP/Postal code |
94305 |
| Country |
USA |
| |
|
| Platform ID |
GPL6244 |
| Series (1) |
| GSE19736 |
GSK-3 inhibitor treatment effect on MLL leukemia cell |
|
